Ovarian Cancer Trial, Recruiting (NCT06642831)

Ovarian Cancer Trial, Recruiting NCT06642831 Sponsor: University Hospital Erlangen Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06642831 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a female between the ages of 15 and 25 years old
You are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

It has been less than 1 year since you had your first period
You are currently using any form of hormonal contraception (such as the pill, patch, hormonal IUD, or implant)
You are currently pregnant
You have significant problems with your ovaries, such as having only one ovary, or cysts or growths larger than 2 cm found on an internal ultrasound scan
You have been diagnosed with cancer, or are currently receiving radiation therapy or chemotherapy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06642831

Sponsor: University Hospital Erlangen

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

More information: https://clinicaltrials.gov/study/NCT06642831

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a female between the ages of 15 and 25 years old
You are willing and able to sign a consent form agreeing to take part in the trial

Who may not be able to join:

It has been less than 1 year since you had your first period
You are currently using any form of hormonal contraception (such as the pill, patch, hormonal IUD, or implant)
You are currently pregnant
You have significant problems with your ovaries, such as having only one ovary, or cysts or growths larger than 2 cm found on an internal ultrasound scan
You have been diagnosed with cancer, or are currently receiving radiation therapy or chemotherapy

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital Erlangen

Registry

ClinicalTrials.gov

Start date

31 January 2023

Est. completion

1 December 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

The validation of new potential biomarkers for aid in the diagnoisis of PCOS in adolescent and young adult women

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov